Table 4.
Percentage of cases with MLPA amplification by gene
| Gene* | % Cases with MLPA amplification | P-value | |
|---|---|---|---|
| ISH polyCEP17 | Non- polyCEP17 | ||
| 17p | |||
| MNT | 0.0 | 12.5 | 0.38 |
| TP53 | 15.4 | 12.5 | 1.00 |
| 17q | |||
| WSB1 | 69.2 | 12.5 | 0.023 |
| TRAF4 | 23.1 | 37.5 | 0.63 |
| CDP | 38.5 | 12.5 | 0.34 |
| NEUROD2 | 46.2 | 25.0 | 0.40 |
| HER2 | 53.8 | 37.5 | 0.66 |
| GRB7 | 38.5 | 50.0 | 0.67 |
| IKZF3 | 61.5 | 25.0 | 0.18 |
| RARA | 7.7 | 25.0 | 0.53 |
| TOP2A | 69.2 | 25.0 | 0.081 |
| BRCA1 | 46.2 | 0.0 | 0.046 |
| MIR21 | 69.2 | 37.5 | 0.20 |
| RPS6KB1 | 15.4 | 0.0 | 0.53 |
| PPM1D | 7.7 | 0.0 | 1.00 |
*Genes PMP22, MFAP4, USP22 (17p); NOS2, SGCA, AXIN2, and UNC13D (17q) were not amplified in any samples.